Patent · US Expired

Treatment of Kaposi's sarcoma with IL-12

US6509321B1 · kind B1 · utility

6Cited by

3References

12Claims

0Family size

Assignee

Genetics Institute, LLC · US

Inventors

Robert Yarchoan · Bethesda, US
James Pluda · Gaithersburg, US
Kathleen Wyvill · Upper Marlboro, US
Jill Lietzau · Columbia, US
Gene M. Shearer · Bethesda, US
Ellen Feigal · Potomac, US
Giovanna Tosato · Bethesda, US
Richard Little · Washington, US
Matthew L. Sherman · Newton, US

Key dates

Filing date	Sep 29, 2000
Grant date	Jan 21, 2003
Priority date	—
Expiry date	Sep 29, 2020

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K48/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods are provided for using IL-12 to treat Kaposi's sarcoma (KS), particularly AIDS-associated KS.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.